Increasing the circulating CTRP9 level is a beneficial action against HFD-induced obesity and glucose intolerance [118], whereas CTRP9-deficiency mice performed exacerbated insulin resistance [119]. This evidence concerns the gene C1QTNF9 and obesity due to melanocortin 4 receptor deficiency.